Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Angiomax® or Unfractionated Heparin for Patients Undergoing Percutaneous Coronary Intervention (STATUS PCI)

This study has been terminated.
(DSMB halted the study early due to futility. There were no safety concerns.)
Information provided by (Responsible Party):
Allen Jeremias, Stony Brook University Identifier:
First received: October 31, 2011
Last updated: November 19, 2014
Last verified: November 2014
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: September 2014
  Primary Completion Date: September 2014 (Final data collection date for primary outcome measure)